Odesivimab is a '' Zaire ebolavirus'' glycoprotein-directed human monoclonal antibody that is part of the fixed-dose combination atoltivimab/maftivimab/odesivimab that is used for the treatment of ''Zaire ebolavirus'' (

Ebola Ebola, also known as Ebola virus disease (EVD) and Ebola hemorrhagic fever (EHF), is a viral hemorrhagic fever in humans and other primates, caused by ebolaviruses. Symptoms typically start anywhere between two days and three weeks after becom ...

virus).

References

External links

* * Ebola Monoclonal antibodies {{antiinfective-drug-stub